Volatile Terpenes in Exhaled Breath: Xenobiotic Biomarkers or Misleading Mirages?

Volatile terpenes and terpenoids in exhaled breath have emerged as intriguing candidates for noninvasive biomarker development, yet their clinical relevance remains debated due to their assumed exogenous origin. This Perspective seeks to review the key literature on exhaled terpenes and highlight their potential as xenobiotic biomarkers to monitor a wide range of medical conditions. Through a fusion of breathomics, pharmacokinetics, and an understanding of cytochrome P450 induced metabolism, we argue that terpenes could report on disease-specific enzymatic activities and offer advantages over traditional endogenous VOCs, particularly toward early-stage detection. We propose strategies for identifying novel terpene substrates, biomarker validation, and integration with nanosensor platforms for point-of-care detection. If realized, xenobiotic terpene/terpenoid biomarkers could represent a paradigm shift in breath-based diagnostics by demonstrating that naturally occurring compounds introduced exogenously can function as intentional probes for noninvasive health monitoring.

Authors

Institutions

Publication Details

Journal
Journal of Breath Research
Published
2026-11-17
DOI
https://doi.org/10.1088/1752-7163/aec31e
Primary Topic
Advanced Chemical Sensor Technologies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Volatile Terpenes in Exhaled Breath: Xenobiotic Biomarkers or Misleading Mirages?

Michael D. Davis, Mangilal Agarwal, Eray Schulz, Mark D. Woollam et al.
Journal of Breath Research
Advanced Chemical Sensor Technologies
article

Volatile Terpenes in Exhaled Breath: Xenobiotic Biomarkers or Misleading Mirages?

Michael D. Davis, Mangilal Agarwal, Eray Schulz, Mark D. Woollam, Eric Long
article en

Abstract

Volatile terpenes and terpenoids in exhaled breath have emerged as intriguing candidates for noninvasive biomarker development, yet their clinical relevance remains debated due to their assumed exogenous origin. This Perspective seeks to review the key literature on exhaled terpenes and highlight their potential as xenobiotic biomarkers to monitor a wide range of medical conditions. Through a fusion of breathomics, pharmacokinetics, and an understanding of cytochrome P450 induced metabolism, we argue that terpenes could report on disease-specific enzymatic activities and offer advantages over traditional endogenous VOCs, particularly toward early-stage detection. We propose strategies for identifying novel terpene substrates, biomarker validation, and integration with nanosensor platforms for point-of-care detection. If realized, xenobiotic terpene/terpenoid biomarkers could represent a paradigm shift in breath-based diagnostics by demonstrating that naturally occurring compounds introduced exogenously can function as intentional probes for noninvasive health monitoring.

Journal of Breath Research
Indiana University Indianapolis (US)
Good health and well-being
Advanced Chemical Sensor Technologies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon